PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
A Pilot Study Of Smoking Cessation Treatment Including Varenicline In Patients Scheduled For Planned Surgery
- First Posted Date
- 2009-04-29
- Last Posted Date
- 2011-10-17
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 16
- Registration Number
- NCT00889720
- Locations
- 🇮🇹
Pfizer Investigational Site, Pisa, Italy
Registry of Etanercept Use in Patients With Rheumatoid Arthritis in Clinical Practice in Taiwan
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2009-04-27
- Last Posted Date
- 2012-02-08
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 441
- Registration Number
- NCT00888576
- Locations
- 🇨🇳
Pfizer Investigational Site, Taoyuan, Taiwan
Study Evaluating The Effects Of Oprelvekin On Cardiac Repolarization In Subjects With Chemotherapy Induced Thrombocytopenia
- First Posted Date
- 2009-04-23
- Last Posted Date
- 2017-04-19
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 19
- Registration Number
- NCT00886743
- Locations
- 🇺🇸
Sarcoma Oncology Center, Santa Monica, California, United States
🇺🇸Pfizer Investigational Site, Laredo, Texas, United States
🇺🇸Montgomery Cancer Center, Mount Sterling, Kentucky, United States
Relapse Prevention Study Of Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder
- Conditions
- Major Depressive Disorder
- Interventions
- First Posted Date
- 2009-04-23
- Last Posted Date
- 2014-11-21
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 874
- Registration Number
- NCT00887224
- Locations
- 🇿🇦
Pfizer Investigational Site, Paarl, South Africa
A Safety and Pharmacokinetic Study of CVX-096 in Type 2 Diabetics
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Biological: CVX-096
- First Posted Date
- 2009-04-23
- Last Posted Date
- 2017-04-18
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 114
- Registration Number
- NCT00886821
- Locations
- 🇺🇸
Cetero Research, Miami Gardens, Florida, United States
🇺🇸Cetero Research - San Antonio, San Antonio, Texas, United States
A Study To Evaluate Whether Food Affects The Plasma Drug Levels Of A 35 mg Single Dose Of PF-04447943 Taken Orally In Healthy Adult Participants
- First Posted Date
- 2009-04-22
- Last Posted Date
- 2009-07-02
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 10
- Registration Number
- NCT00886093
- Locations
- 🇺🇸
Pfizer Investigational Site, New Haven, Connecticut, United States
Study To Evaluate The Safety And Efficacy Of ILV-094 In Subjects With Rheumatoid Arthritis
- First Posted Date
- 2009-04-20
- Last Posted Date
- 2022-10-21
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 195
- Registration Number
- NCT00883896
- Locations
- 🇺🇸
Deaconess Hospital, Cincinnati, Ohio, United States
🇧🇪Chu Liege Sart Tilman B 35, Liege, Belgium
🇺🇸Clinical Research Advantage, Inc., Sarasota, Florida, United States
Study Evaluating Safety Of Patients Switching To ReFacto AF In Usual Care Settings
- Conditions
- Hemophilia A
- Interventions
- Drug: moroctocog alfa (AF-CC) (ReFacto AF)Procedure: Laboratory tests
- First Posted Date
- 2009-04-20
- Last Posted Date
- 2014-09-01
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 208
- Registration Number
- NCT00884390
- Locations
- 🇬🇧
Pfizer Investigational Site, Manchester, United Kingdom
Study Evaluating Bosutinib-Letrozole Combination Versus Letrozole Alone In Post Menopausal Women With Breast Cancer
- First Posted Date
- 2009-04-13
- Last Posted Date
- 2021-09-27
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 16
- Registration Number
- NCT00880009
- Locations
- 🇭🇺
Orszagos Onkologiai Intezet "B" Belgyogyaszati osztaly, Budapest, Hungary
🇺🇸American Institute of Research, Whittier, California, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
An Open Label, Randomized, Crossover Study To Estimate The Pharmacokinetics And Evaluate The Safety Following A Single Dose Of Azithromycin 2g Extended-Release Powder For Oral Suspension With A 3-Day Dosing Regimen Of Azithromycin 500mg Tablet In Chinese Healthy Male Subjects
- First Posted Date
- 2009-04-13
- Last Posted Date
- 2010-06-14
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 24
- Registration Number
- NCT00879983
- Locations
- 🇨🇳
Pfizer Investigational Site, Shanghai, China